ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma

Xia, Haoming; Huang, Ziyue; Wang, Zhensheng; Liu, Shuqiang; Zhao, Xudong; You, Junqi; Xu, Yi*; Yam, Judy Wai Ping*; Cui, Yunfu*哈尔滨医科大学; y
Frontiers in Oncology2022-7-15DOI: 10.3389/fonc.2022.953668
5被引8阅读
引用收藏
分享

摘要

Glucose, the central macronutrient, releases energy as ATP through carbon bond oxidation and supports various physiological functions of living organisms. Hepatocarcinogenesis relies on the bioenergetic advantage conferred by glucometabolic reprogramming. The exploitation of reformed metabolism induces a uniquely inert environment conducive to survival and renders the hepatocellular carcinoma (HCC) cells the extraordinary ability to thrive even in the nutrient-poor tumor microenvironment. The rewired metabolism also confers a defensive barrier which protects the HCC cells from environmental stress and immune surveillance. Additionally, targeted interventions against key players of HCC metabolic and signaling pathways provide promising prospects for tumor therapy. The active search for novel drugs based on innovative mutation targets is warranted in the future for effectively treating advanced HCC and the preoperative downstage. This article aims to review the regulatory mechanisms and therapeutic value of glucometabolic reprogramming on the disease progression of HCC, to gain insights into basic and clinical research.

学科与关键词

关键词
hepatocellular carcinomaglucometabolic reprogrammingtumor microenvironmentdrug resistanceantitumor agentsenvironmental stress
相关
加载中…
  • Reprogramming of central carbon metabolism in hepatocellular carcinoma
    Xia, Haoming; Huang, Ziyue; Xu, Yi*; Yam, Judy Wai Ping*; Cui, Yunfu*Biomedicine and Pharmacotherapy, 2022, 153: 113485.被引 8
  • Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy
    Yang, Jiabin; Zeng, Liangtang; Chen, Ruiwan; Zheng, Shangyou; Zhou, Yu*; Chen, Rufu*Frontiers in Immunology, 2023, 14: 1076587.
  • Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma
    Wang, Siyuan; Li, Yiling; Liu, Ning; Shen, Wei; Xu, Wenhao; Yao, Peng*Genetical Research, 2022, 2022: 8566342.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-07-15
卷期
第 12 卷
页码
953668
DOI
10.3389/fonc.2022.953668
期刊等级
3区
成果收录
SCIE
资助标注
Hong Kong Scholars Program [XJ2020012]; National Natural Science Foundation of China [81902431]; Special Project of China Postdoctoral Science Foundation [2019T120279]; China Postdoctoral Science Foundation [2018M641849, 2018M640311]; Postgraduate Innovative Research Project of Harbin Medical University [YJSCX2016-21HYD]; Foundation of Key Laboratory of Myocardial Ischemia, Ministry of Education [KF201810]; Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province [CXPJJH11800004-001, CXPJJH11800004-003]

作者

  • X

    Xia, Haoming (第一作者)

    2 · harbin med univ

  • H

    Huang, Ziyue

    2 · harbin med univ

查看全部 9 位作者收起作者
  • W

    Wang, Zhensheng

    2 · harbin med univ

  • L

    Liu, Shuqiang

    2 · harbin med univ

  • Z

    Zhao, Xudong

    2 · harbin med univ

  • Y

    You, Junqi

    2 · harbin med univ

  • X

    Xu, Yi (通讯)

    2 · harbin med univ · univ hong kong

  • Y

    Yam, Judy Wai Ping (通讯)

    univ hong kong

  • C

    Cui, Yunfu (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417